PARI Swiss AG is a company focused on inhalation therapy and the development of nebuliser devices. Its portfolio includes inhalation devices (e.g. PARI BOY, PARI COMPACT), eFlow® membrane nebuliser technology for pharmaceutical partnering, and supporting services such as professional training and educational information.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Inhalation therapy for respiratory conditions, including nebulizer systems, metered-dose inhalers, dry-powder inhalers, and valved holding chambers/spacers.
Nebulizers
Nebulizers for the treatment of asthma, COPD, cystic fibrosis, and other respiratory conditions; including jet nebulizers and vibrating-membrane nebulizers for medicines and saline solutions.
PARI BOY
Robust nebulizer devices for at-home inhalation, focused on quality and reliability.
PARI SINUS2
Pulsating aerosol device for the treatment of sinusitis in the nose and paranasal sinuses.
PARI COMPACT2
Nebulizer device for the treatment of lower respiratory tract conditions.
Knowledge
No knowledge articles yet
Once PARI Swiss AG has claimed this profile, we'll publish editorial articles and case studies here together.